Pharma Journalist -

Nutriband Inc announced the formal completion of the acquisition of Atlanta-based 4P Therapeutics Inc. Pursuant to the previously announced acquisition agreement, on Aug 1, 2018,…
Read More...

Players throughout the pharmaceutical supply chain are experiencing growing pressure to gain accreditation for handling the high-value, temperature-sensitive cargo, as having a…
Read More...

SMi are delighted to have interviewed Mitchell de Long, Vice President, Chemistry, Aerie Pharmaceuticals regarding his thoughts and experiences within the ophthalmology space.…
Read More...

The lengthening shadow of increase in health spending in the coming years is sharpening the minds of legislators, regulators and payers alike. The growing time-to-market, the rising…
Read More...

Puma Biotechnology announced that Health Canada has accepted for review the Company’s New Drug Submission (NDS) for the medicinal product NERLYNX (neratinib) for the extended adjuvant…
Read More...

LEO Pharma and Bayer announced that LEO Pharma has entered into a definitive agreement to buy Bayer’s global prescription dermatology unit. The portfolio to be acquired includes branded…
Read More...

Takeda Pharmaceutical Company Limited and TiGenix NV announced that Takeda has acquired all outstanding ordinary shares (including Ordinary Shares represented by American Depositary…
Read More...

IBSA Group, the largest privately owned pharmaceutical company in Switzerland, has established a commercial presence in the United States as IBSA Pharma Inc. and is planning to directly…
Read More...

HiFiBiO Therapeutics announced a multi-target agreement with Takeda Pharmaceutical Company Limited (Takeda) to enable the discovery of breakthrough antibody therapies to potentially…
Read More...

Nektar Therapeutics announced that the U.S. Food and Drug Administration (FDA) has filed and accepted for review the company's New Drug Application (NDA) for NKTR-181 for the treatment…
Read More...